PlantExt

The future of clinically tested and proven medical cannabis

PlantEXT is developing and commercializing the world’s most effective medical cannabis formulations for the treatment of Inflammation. PlantEXT has entered into a strategic partnership with the State of Israel’s Agricultural Research Organization (“ARO”) to develop and commercialize a treatment for Inflammatory Bowel Diseases, including Crohn’s and Colitis.

PlantEXT conducts pre-clinical studies in collaboration with ARO and at PlantEXT’s independent dedicated research facilities in Tel Aviv, focusing on unique combinations of cannabinoids that create synergistic anti-inflammatory activity and result in new genetic pathways targeted for the treatment of inflammation-related conditions.

Brands: PlantEXT Ltd.